A Study to Assess Safety and PK of Liquid Alpha₁-Proteinase Inhibitor (Human) in Treating Alpha₁-Antitrypsin Deficiency

NCT02282527 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

32

Enrollment

INDUSTRY

Sponsor class

Conditions

Alpha₁-Antitrypsin Deficiency

Interventions

BIOLOGICAL: Liquid Alpha₁-PI
BIOLOGICAL: Prolastin-C

Sponsor

Grifols Therapeutics LLC